» Articles » PMID: 16483832

Activation of ERK1/2 and Cyclin D1 Expression in Oral Tongue Squamous Cell Carcinomas: Relationship Between Clinicopathological Appearances and Cell Proliferation

Overview
Journal Oral Oncol
Publisher Elsevier
Specialty Dentistry
Date 2006 Feb 18
PMID 16483832
Citations 20
Authors
Affiliations
Soon will be listed here.
Abstract

We report an immunohistochemical investigation of the expression of activated extracellular signal-regulated kinase (ERK1/2) and cyclin D1 protein in both oral tongue squamous cell carcinomas (OTSCCs) and normal tongue epithelium. The expression of Ki-67 labeling index (LI) was also examined in order to evaluate cell proliferation activity. The expression of activated ERK1/2, cyclin D1 protein and Ki-67 LI were significantly stronger in OTSCCs than in normal oral mucosa (P<0.05). Both over-expression of activated ERK1/2 and positive expression of Ki-67 in OTSCCs were significantly associated with a moderately or poorly differentiated grade of carcinoma (P<0.05). Cyclin D1 immunostaining showed statistically significant association with both lymph node metastasis (P<0.05) and a tumor thickness >5mm (P<0.05). Over-expression of activated ERK1/2 was positively correlated with cyclin D1 protein expression (P<0.05, r=0.624) and cell proliferation-related indexes Ki-67 (P<0.05, r=0.723). Our results suggest that over-expression of activated ERK1/2 and cyclin D1 protein are involved in oral tongue carcinogenesis, and that activation of ERK1/2 might be related to cell cycle regulation and cell proliferation in OTSCCs.

Citing Articles

Modelling the disease: HS-sensitivity and drug-resistance of triple negative breast cancer cells can be modulated by embedding in isotropic micro-environment.

Buonvino S, Arciero I, Martinelli E, Seliktar D, Melino S Mater Today Bio. 2023; 23:100862.

PMID: 38046276 PMC: 10689286. DOI: 10.1016/j.mtbio.2023.100862.


Nuclear Epidermal Growth Factor Receptor Overexpression as a Survival Predictor in Oral Squamous Cell Carcinoma.

Tarle M, Raguz M, Muller D, Luksic I Int J Mol Sci. 2023; 24(6).

PMID: 36982894 PMC: 10056291. DOI: 10.3390/ijms24065816.


BTK Isoforms p80 and p65 Are Expressed in Head and Neck Squamous Cell Carcinoma (HNSCC) and Involved in Tumor Progression.

Betzler A, Strobel H, Kors T, Ezic J, Lesakova K, Pscheid R Cancers (Basel). 2023; 15(1).

PMID: 36612306 PMC: 9818583. DOI: 10.3390/cancers15010310.


Chordin-Like 1 Regulates Epithelial-to-Mesenchymal Transition and Metastasis the MAPK Signaling Pathway in Oral Squamous Cell Carcinoma.

Wu Q, Zheng Z, Zhang J, Piao Z, Xin M, Xiang X Front Oncol. 2022; 12:862751.

PMID: 35494000 PMC: 9046701. DOI: 10.3389/fonc.2022.862751.


Loss of TACC1 variant25 inducing cell proliferation and suppressing autophagy in head and neck squamous carcinoma.

Xu P, Zhao R, Zhang C, Zhang Q, Wang Y, Zhu J Cell Death Discov. 2021; 7(1):386.

PMID: 34897285 PMC: 8665927. DOI: 10.1038/s41420-021-00777-6.